Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Let's Talk About Our Feelings!!! -- Ignore unavailable to you. Want to Upgrade?

To: Grainne who wrote (107322)	8/8/2005 10:45:52 AM
From: Henry Niman	Read Replies (1) \| Respond to of 108807

If the vaccine does work against the immunogen, it won't work against an immunogen that has mutated further away. If the idea was just to stick H5 into people, they could have used H5 made against the 1997 H5N1. It takes 18X normal just to get a borderline response which may not even help if infected with 2004 from Vietnam. If just a little would work, there would not be discussions of s THIRD dose. recombinomics.com Basically, the vaccine doesn't work well at all in the group most able to mount an immunological response. I don't think anyone is going to roll up there sleeve to see what happens if they have bben given a weak immungen followed by pandemic H5N1.